Gina Fridley is a member of our Healthcare & Life Sciences practice.
She has worked with private equity funds, hedges, funds, pharmaceuticals and biotechnology. Her work has been conducting due diligence, radar 360 strategy, and resource allocation across a range of sectors. She currently is conducting sector screening and review with financial investors.
Gina earned her PhD in bioengineering from the University of Washington and graduated with a BS in biological engineering from the Massachusetts Institute of Technology (MIT).